Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
January 26, 2010
Preclinical development of AS04
Nathalie Garçon
Human Vaccines & Immunotherapeutics
|
September 17, 2016
From discovery to licensure, the Adjuvant System story
Nathalie Garçon, Alberta Di Pasquale
Expert Review of Vaccines
|
April 22, 2011
Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems
Nathalie Garçon, Marcelle Van Mechelen
Expert Opinion on Biological Therapy
|
April 5, 2011
Role of AS04 in human papillomavirus vaccine: mode of action and clinical profile
Nathalie Garçon, Martine Wettendorff, Marcelle Van Mechelen
Expert Review of Vaccines
|
October 13, 2007
GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives
Nathalie Garçon, Patrick Chomez, Marcelle Van Mechelen
Expert Review of Vaccines
|
August 6, 2003
Development of RTS,S/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant
Nathalie Garçon, D Gray Heppner, Joe Cohen
Expert Review of Vaccines
|
March 3, 2012
Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion
Nathalie Garçon, David W Vaughn, Arnaud M Didierlaurent
Vaccine
|
April 30, 2011
The safety evaluation of adjuvants during vaccine development: the AS04 experience
Nathalie Garçon, Lawrence Segal, Fernanda Tavares, et al.
Journal of Applied Toxicology : JAT
|
March 11, 2015
Non-clinical safety assessment of single and repeated intramuscular administration of a human papillomavirus-16/18 vaccine in rabbits and rats
Lawrence Segal, Danielle Morelle, Kari Kaaber, et al.
Regulatory Toxicology and Pharmacology : RTP
|
June 24, 2015
Effects of Adjuvant Systems on the cardiovascular and respiratory functions in telemetered conscious dogs and anaesthetised rats
Lawrence Segal, Virginie Roger, Colin Williams, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Methods in Molecular Biology (Clifton, N.J.)
|
January 26, 2010
Preclinical development of AS04
Nathalie Garçon
Human Vaccines & Immunotherapeutics
|
September 17, 2016
From discovery to licensure, the Adjuvant System story
Nathalie Garçon, Alberta Di Pasquale
Expert Review of Vaccines
|
April 22, 2011
Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems
Nathalie Garçon, Marcelle Van Mechelen
Expert Opinion on Biological Therapy
|
April 5, 2011
Role of AS04 in human papillomavirus vaccine: mode of action and clinical profile
Nathalie Garçon, Martine Wettendorff, Marcelle Van Mechelen
Expert Review of Vaccines
|
October 13, 2007
GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives
Nathalie Garçon, Patrick Chomez, Marcelle Van Mechelen
Expert Review of Vaccines
|
August 6, 2003
Development of RTS,S/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant
Nathalie Garçon, D Gray Heppner, Joe Cohen
Expert Review of Vaccines
|
March 3, 2012
Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion
Nathalie Garçon, David W Vaughn, Arnaud M Didierlaurent
Vaccine
|
April 30, 2011
The safety evaluation of adjuvants during vaccine development: the AS04 experience
Nathalie Garçon, Lawrence Segal, Fernanda Tavares, et al.
Journal of Applied Toxicology : JAT
|
March 11, 2015
Non-clinical safety assessment of single and repeated intramuscular administration of a human papillomavirus-16/18 vaccine in rabbits and rats
Lawrence Segal, Danielle Morelle, Kari Kaaber, et al.
Regulatory Toxicology and Pharmacology : RTP
|
June 24, 2015
Effects of Adjuvant Systems on the cardiovascular and respiratory functions in telemetered conscious dogs and anaesthetised rats
Lawrence Segal, Virginie Roger, Colin Williams, et al.
Page
of 5